2015


To access this material please log in or register

Register Authorize
2015/№5

Features of structural and functional myocardial remodeling in patients with chronic obstructive pulmonary disease and CHF

Karoli N. A.1, Borodkin A. V.1, Lukjyanova L. V.2, Rebrov A. P.1
1 – State Budgetary Educational Institution of Higher Professional Education, “V. I. Razumovsky Saratov State Medical University” of the RF Ministry of Health Care, Bolshaya Kazachjya 112, Saratov 410012
2 – State Health Care Institution, “Regional Clinical Hospital”, Smirnovskoe Ushchelje 1, Saratov 410053

Keywords: chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary heart disease, myocardial remodeling, CHF

DOI: 10.18087 / rhfj.2015.5.2112

Background. In Russia, COPD is one of the most important causes for development of CHF (13 % of cases). Different authors have reported that CHF is observed in 62 % of older-age patients with COPD. Aim. To study features of structural and functional myocardial remodeling in COPD patients with and without CHF and in presence of CHF of different origins. Materials and method. In accordance with the study aim, 210 men with COPD were evaluated. Patients were selected as a random sample. 112 (36.2 %) of the evaluated COPD patients had signs of HF. Patients with CHF signs were divided into two groups, with (75 patients) and without (37 patients) a history of MI. Results. In COPD patients with CHF, pulmonary systolic pressure was significantly higher than in COPD patients without CHF. Hypertrophy of the RV anterior wall was observed in the vast majority of COPD patients both with and without CHF. RV EDR was significantly greater in COPD patients with HF than in healthy individuals. 75.6 % of COPD patients without CHF and 81 % of patients with CHF had impaired RV diastolic function. LV EF was significantly lower in COPD patients with CHF than in patients without CHF. In CHF patients with a history of MI, LV EF was significantly lower than in CHF patients without a history of MI. Disorders of LV diastolic function were observed in 77.8 % of patients without CHF and 79.5 % of patients with CHF. Conclusion. The obtained data indicated significance of RV diastolic dysfunction in development of HF in COPD patients with stable pulmonary hypertension. Alterations in LV were moderate and were not determinant in the clinical picture of disease. However LV dysfunction can aggravate already existing hemodynamic disorders of both systemic and pulmonary circulation.
  1. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000 Jul 27;343 (4):269–80.
  2. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003 May 15;348 (20):2007–18.
  3. Мареев В. Ю., Агеев Ф. Т., Арутюнов Г. П., Коротеев А. В., Мареев Ю. В., Овчинникова А. Г. и др. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр). Журнал Сердечная Недостаточность. 2013;14 (7):379–472.
  4. Кароли Н. А., Ребров А. П. Хроническая обструктивная болезнь легких и кардиоваскулярная патология. Клиницист. 2007;1:13–9.
  5. Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, Kessler R. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest. 1995 May;107 (5):1193–8.
  6. Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognosis value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981 Oct;36 (10):752–8.
  7. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992 Jun;19 (7):1550–8.
  8. Weitzenblum E, Chaouat A. Severe pulmonary hypertension in COPD: is it a distinct disease? Сhest. 2005 May;127 (5):1480–2.
  9. Enright PL, Kronmal RA, Smith VE, Gardin JM, Schenker MB, Manolio TA. Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study. Chest. 1995 Jan;107 (1):28–35.
  10. Meysman M, Pipeleers-Marichal M, Geers C, Ilsen B, Vincken W. Severe right heart failure in a patient with chronic obstructive lung disease: a diagnostic challenge. Indian J Chest Dis Allied Sci. 2013 Jul-Sep;55 (3):159–62.
  11. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW. Unreconized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005 Sep;26 (18):1887–94.
  12. Caram LM, Ferrari R, Naves CR, Tanni SE, Coelho LS, Zanati SG et al. Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease. Clinics (Sao Paulo). 2013 Jun;68 (6):772–6.
Karoli N. A., Borodkin A. V., Lukjyanova L. V., Rebrov A. P. Features of structural and functional myocardial remodeling in patients with chronic obstructive pulmonary disease and CHF. Russian Heart Failure Journal. 2015;16 (5):279–287

To access this material please log in or register

Register Authorize
Ru En